Company intelligence / Profile preview

HMR Labs

London, London, United Kingdomhmrlondon.com ↗

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Hammersmith Medicines Research (HMR) is a premier contract research organization (CRO) specializing in Phase 1 and early Phase 2 clinical trials. Based in London, UK, the company operates one of Europe's largest Phase 1 units, featuring a 100-bed facility and integrated laboratory services. HMR provides comprehensive support for early-stage drug development, including first-in-human studies, trial design, and regulatory consultancy. Their expertise spans a wide range of therapeutic modalities, serving global pharmaceutical and biotechnology clients. The company is located within the Central Middlesex Hospital, providing a unique clinical environment for complex research protocols.

Modalities: Small moleculeMonoclonal antibodyVaccineGene therapyCell therapy
Industry: Contract Research Organization

Beyond the preview

Go deeper on HMR Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HMR Labs.

Explore the full profile